Elevance Health (WBO:ELV) Piotroski F-Score: 5 (As of Jun. 28, 2026) — 17% Below Median


WBO:ELV Elevance Health Inc WBO:ELV
84 GF Score
Price €344.20
GF Value €442.94
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Elevance Health Piotroski F-Score?

Elevance Health WBO:ELV +1.35% 84 Piotroski F-Score is 5 as of Jun. 28, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates WBO:ELV with a GF Score™ of 84/100 and a GF Value™ of €442.94 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 18 Healthcare Plans companies, Elevance Health ranks worse than 72.22% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Elevance Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Elevance Health's Piotroski F-Score or its related term are showing as below:

WBO:ELV' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Elevance Health was 8. The lowest was 3. And the median was 6.

Elevance Health  (WBO:ELV) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Elevance Health Piotroski F-Score Related Terms


Elevance Health Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Elevance Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health Piotroski F-Score Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 6.00 7.00 3.00 6.00

Elevance Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 5.00 4.00 6.00 5.00

WBO:ELV vs CI, CVS, HUM: Piotroski F-Score Comparison

For the Healthcare Plans subindustry, Elevance Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elevance Health Piotroski F-Score vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Elevance Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Elevance Health's Piotroski F-Score falls into.


WBO:ELV
84GF Score
Elevance Health Inc WBO:ELV
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 1511.181 + 1013.028 + 467.138 + 1525.86 = €4,517 Mil.
Cash Flow from Operations was 1780.818 + 967.02 + 71.736 + 3747.18 = €6,567 Mil.
Revenue was 43155.792 + 43205.772 + 42483.938 + 43406.565 = €172,252 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(110738.225 + 105720.246 + 104582.148 + 103755.876 + 108840.355) / 5 = €106727.37 Mil.
Total Assets at the begining of this year (Mar25) was €110,738 Mil.
Long-Term Debt & Capital Lease Obligation was €26,614 Mil.
Total Assets was €108,840 Mil.
Total Liabilities was €70,744 Mil.
Net Income was 2136.7 + 915.416 + 399.19 + 2019.275 = €5,471 Mil.

Revenue was 40547.134 + 40675.645 + 43397.11 + 45224.175 = €169,844 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(102942.48 + 104965.852 + 104996.233 + 111628.995 + 110738.225) / 5 = €107054.357 Mil.
Total Assets at the begining of last year (Mar24) was €102,942 Mil.
Long-Term Debt & Capital Lease Obligation was €26,002 Mil.
Total Assets was €110,738 Mil.
Total Liabilities was €71,315 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Elevance Health's current Net Income (TTM) was 4,517. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Elevance Health's current Cash Flow from Operations (TTM) was 6,567. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=4517.207/110738.225
=0.04079176

ROA (Last Year)=Net Income/Total Assets (Mar24)
=5470.581/102942.48
=0.05314211

Elevance Health's return on assets of this year was 0.04079176. Elevance Health's return on assets of last year was 0.05314211. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Elevance Health's current Net Income (TTM) was 4,517. Elevance Health's current Cash Flow from Operations (TTM) was 6,567. ==> 6,567 > 4,517 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=26614.32/106727.37
=0.24936734

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=26001.75/107054.357
=0.24288362

Elevance Health's gearing of this year was 0.24936734. Elevance Health's gearing of last year was 0.24288362. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

* Note that for banks and insurance companies, there's no Total Current Assets and Total Current Liabilities reported. Thus, we use Total Assets and Total Liabilities to calculate current ratio for banks and insurance companies.

Current Ratio (This Year: Mar26)=Total Assets/Total Liabilities
=108840.355/70744.025
=1.53850951

Current Ratio (Last Year: Mar25)=Total Assets/Total Liabilities
=110738.225/71314.725
=1.5528101

Elevance Health's current ratio of this year was 1.53850951. Elevance Health's current ratio of last year was 1.5528101. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Elevance Health's number of shares in issue this year was 220.4. Elevance Health's number of shares in issue last year was 227.2. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

* Note that for banks and insurance companies, there's no Gross Profit reported. Thus, we use net income instead of gross profit and calculate Net Margin for this score.

Net Margin (This Year: TTM)=Net Income/Revenue
=4517.207/172252.067
=0.0262244

Net Margin (Last Year: TTM)=Net Income/Revenue
=5470.581/169844.064
=0.03220943

Elevance Health's net margin of this year was 0.0262244. Elevance Health's net margin of last year was 0.03220943. ==> Last year's net margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=172252.067/110738.225
=1.55548878

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=169844.064/102942.48
=1.64989287

Elevance Health's asset turnover of this year was 1.55548878. Elevance Health's asset turnover of last year was 1.64989287. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+0+1+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Elevance Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Elevance Health (WBO:ELV) has a Piotroski F-Score of 5 as of Jun. 28, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Elevance Health and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Elevance Health's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Elevance Health ranks #13 out of 18 companies in the Healthcare Plans industry, placing it in the top 72.2%.
Is Elevance Health's Piotroski F-Score too high?
Elevance Health's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Healthcare Plans industry median Piotroski F-Score is 6.00. Elevance Health's value of 5 is 16.7% below this industry median. Based on the distribution chart, Elevance Health ranks #13 out of 18 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Elevance Health has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Piotroski F-Score compare to CI and CVS?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #13 out of 18 companies for Piotroski F-Score. This places Elevance Health in the lower half of its industry. The industry median Piotroski F-Score is 6.00. Elevance Health's value of 5 is 16.7% below this benchmark. Historically, Elevance Health's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 6.00, Elevance Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Plans company?
The median Piotroski F-Score among Healthcare Plans companies is 6.00, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current Piotroski F-Score of 5 is 16.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median Piotroski F-Score is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (WBO:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is €442.94, compared to a current price of €344.20 — trading 22.3% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 16.7% below the Healthcare Plans industry median of 6.00. Elevance Health's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Elevance Health (WBO:ELV), the current Piotroski F-Score is 5 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (WBO:ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of €344.20 is trading 22.3% below its estimated GF Value™ of €442.94. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for WBO:ELV:

  • Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
  • GF Value™: €442.94 vs. price of €344.20 (22.3% below fair value)
  • GF Score™: 84/100 with 7 warning signs
  • Industry Position: 16.7% below the Healthcare Plans median (#13 of 18)

No single metric tells the full story. See the WBO:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
84GF Score

Get the complete analysis for WBO:ELV

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€344.20
Price
€442.94
GF Value